diag nosis of p sychosis not otherwise sp ecifi ed and tried comb ined trials of selectiv e serotonin reup take inhib itors (SSR Is) for his ob sessiv e-comp ulsiv e symp toms (e.g ., p arox etine and escitalop ram) and antip sychotics (e.g ., olanz ap ine, risp eridone, and halop eridol) for his p sychotic symp toms, b ut Carlos could not tolerate a full trial of these medications b ecause of dose-limiting side effects. Increased social isolation, p oor school p erformance, and increased v erb al arg uments at work for 1 month b efore this p resentation led to Carlos's family b ring ing him to the emerg ency dep artment. Carlos had no history of sub stance use or sig nifi cant medical p roblems. H is family history was notab le for a maternal aunt with O CD and a p aternal uncle with schiz op hrenia.
Carlos was admitted from the emerg ency dep artment to the p sychiatric inp atient unit with a p rov isional diag nosis of schiz op hrenia in addition to the estab lished diag nosis of O CD. Major dep ression with p sychotic features was ruled out b ecause of his euthymic mood; normal sleep, interest, ap p etite, and energ y; and lack of ev idence of inap p rop riate g uilt or suicidality. H is medication reg imen on admission was sertraline, 2 0 0 mg / day, and arip ip raz ole, 2 0 mg /day. O n ex amination, he was noted to b e a tall, thin male with thick, b rown chinleng th hair. H e had p oor eye contact and sat hunched in his chair. H e had b lunted affect, sp eech latency, thoug ht b locking , and lack of interp ersonal relatedness. H e was comp letely conv inced that he had " lines" coming out of his mouth and g enitals. From Carlos's descrip tion, it was ap p arent that he p erceiv ed these lines as a v isual hallucination. H e b eliev ed a force outside of his b ody was causing them to ap p ear and that they were an ex tension of his b ody. O n the inp atient unit, he was ob serv ed to b e talking and laug hing to himself during meals. Carlos b eliev ed that the hosp ital staff were making disp arag ing comments ab out him. O n the inp atient unit, he was ob serv ed to rearrang e items in his room for up to 3 hours a day; howev er, he was unab le to articulate the motiv ation b ehind this b ehav ior, althoug h this may hav e b een due to his thoug ht disorder and latency of sp eech.
Case Presentation
Chief Complaint " Carlos," a 1 9 -year-old Puerto R ican male with no p rior p sychiatric hosp italiz ations, p resented at the emerg ency dep artment with the b elief that " lines" were coming out of his mouth and g enitals. H e also sp ent sev eral hours a day org aniz ing ob jects in his house and checking to make sure they were alig ned p erfectly symmetrically.
History of Present Illness
Two years earlier, Carlos b eg an feeling lonely and dep ressed and felt as if the other memb ers of the school b asketb all team did not like him and p erhap s ev en wanted to hurt him. Sev eral months later, he b eg an hav ing rep eated intrusiv e thoug hts that if ob jects were not ex actly alig ned, some v ag ue catastrop hic ev ent mig ht occur, and this made him feel v ery anx ious. In resp onse to these thoug hts, he p erformed rep etitiv e b ehav iors to reduce his anx iety, including the arrang ing and rearrang ing of items and cutting and recutting his fi ng ernails until p erfectly symmetrical. T hese rep etitiv e b ehav iors often took up to 5 hours a day. H e recog niz ed these thoug hts as unreasonab le, ex cessiv e, and a p roduct of his own imag ination. In fact, he was p uz z led as to why he would b e so concerned with symmetry. H is family took him to see a p sychiatrist soon after the start of the symp toms, and he was diag nosed as hav ing ob sessiv e-comp ulsiv e disorder (O CD ). Althoug h he had occasional low mood, he did not meet criteria for dysthymia or major dep ression. Consecutiv e trials of fl uox etine (8 0 mg /day for 4 months) and citalop ram (6 0 mg /day for 3 months) failed b ecause of lack of effi cacy. Six months b efore the current p resentation, he withdrew from his family, sp ending most of his free time in his room. At his p art-time job in a g rocery store, he dev elop ed delusional b eliefs that coworkers and customers were taunting him. T his led to v erb al fi g hts with multip le coworkers and yelling at a customer. H is p sychiatrist added the When a patient presents with both psychotic and obsessive-compulsive symptoms, the clinician is faced with a differential diagnosis that includes comorbid schizophrenia and obsessive-compulsive disorder (OCD), OCD with poor insight, and schizophrenia with antipsychoticinduced obsessive-compulsive symptoms.
If the psychotic symptoms are subthreshold or attenuated in form, the individual may have OCD and putative prodromal schizophrenia. The authors present a case to outline a strategy for differentiating among these possible diagnoses and for optimizing treatment.
D ifferential D iag nosis
The differential diagnosis of a patient who presents with both psychotic and obsessive-compulsive symptoms can include comorbid schizophrenia and obsessive-compulsive disorder, OCD with poor insight, or schizophrenia with antipsychotic-induced obsessive-compulsive symptoms. If the psychotic symptoms are subthreshold or attenuated in form, the individual may have OCD and putative prodromal schizophrenia (3) . No biological markers exist to differentiate these possibilities, and there is debate as to the relationship of schizophrenia and OCD, especially early in the course of evolving symptoms. However, accurate diagnosis is important given that current treatments for OCD and schizophrenia differ, and first-line medications for one may exacerbate the symptoms of the otherthat is, antipsychotics can exacerbate obsessive-compulsive symptoms, and SRIs may exacerbate psychosis (4). As there is no evidence base for the treatment of putative prodromal schizophrenia, OCD that occurs in this context should be treated pharmacologically as though it existed alone, although the attenuated positive symptoms should be monitored.
The choice of diagnoses made has prognostic implications. For example, the presence of obsessive-compulsive symptoms or comorbid OCD in a person with schizophrenia has been associated with poorer prognosis (5, 6) and a significantly higher risk of suicide attempt (7) . In individuals who are at heightened risk for psychosis or are in a putative prodromal stage of schizophrenia, the presence of obsessivecompulsive symptoms in addition to attenuated positive symptoms is associated with a greater prevalence of depression and suicidal ideation (3) . OCD with poor insight is associated with poor response to therapy (8) and drug treatment (9) . Hence, accurate diagnosis of patients with both psychotic and obsessive-compulsive symptoms is important for treatment and prognosis.
When a patient presents with the hallmarks of schizophrenia-hallucinations, disorganized speech and behavior, negative symptoms, and delusions (i.e., "erroneous beliefs that usually involve a misinterpretation of perceptions or experiences" [10, p. 299] )-the diagnosis is usually straightforward. Likewise, when a patient presents with the hallmarks of OCD-obsessions ("recurrent or persistent thoughts, impulses, or images…[that are]…intrusive and inappropriate and that cause marked anxiety or distress" [10, p. 462] ) and compulsions ("repetitive behaviors…or mental acts…that the person feels driven to perform in response to an obsession… [and] …are aimed at… reducing distress or preventing some dreaded event"[10, p. 462])-and has good insight into the irrationality of his
Treatment Course
O n the inp atient unit, Carlos's admission medication reg imen (sertraline and arip ip raz ole) was tap ered b ecause of lack of effi cacy. Cloz ap ine was initiated to treat Carlos's relativ ely refractory p sychotic symp toms, g iv en the history of multip le failed antip sychotic trials and a case series on the treatment of ob sessiv e-comp ulsiv e symp toms in p atients with schiz op hrenia (1 ). After slow titration to 3 0 0 mg /day ov er 1 0 weeks while monitoring the ob sessiv e-comp ulsiv e symp toms to ensure that they did not worsen, Carlos stop p ed talking and laug hing to himself. H e also rep orted that he no long er felt " p icked on" or saw lines. H owev er, he continued to hav e sig nifi cant ob sessions (the need to hav e items alig ned symmetrically) and comp ulsions (arrang ing ) for 3 hours a day. W ith the clearing of his thoug ht disorder, Carlos was ag ain ab le to articulate that alig ning ob jects in a symmetrical fashion was something he did to allev iate anx iety.
W ith his p sychotic symp toms noticeab ly imp rov ed with cloz ap ine treatment, Carlos was discharg ed to the care of his outp atient p sychiatrist. To targ et his p ersistent ob sessiv e-comp ulsiv e symp toms, seq uential trials of fl uv ox amine and then clomip ramine (two serotonin reuptake inhib itors [SR Is] he had not p rev iously tried) were recommended. Careful monitoring would b e needed for these trials of comb ined cloz ap ine and SR Is, as fl uv oxamine inhib its the metab olism of cloz ap ine v ia hep atic cytochrome 3 A4 and clomip ramine decreases the seiz ure threshold, is anticholinerg ic, and affects cardiac conduction. T he p lan was also to add cog nitiv e-b ehav ioral therap y (CB T ) using ex p osure and resp onse p rev ention for any residual ob sessiv e-comp ulsiv e symp toms once Carlos was stab le on an outp atient medication reg imen.
At 6 -month follow-up, Carlos's p sychotic symp toms were ob serv ed to hav e remitted with a dose of 3 0 0 mg /day of cloz ap ine (the minimal dose req uired for treatment of his p sychosis). H owev er, his ob sessiv e-comp ulsiv e symptoms continued to cause him distress and p rob lems in daily functioning . H e then had the recommended trials of fl uv ox amine (2 5 0 mg /day for 3 months) and then clomip ramine (2 2 5 mg /day for 3 months), neither of which was effectiv e in treating his ob sessiv e-comp ulsiv e symp toms. A trial of CB T using ex p osure and resp onse p rev ention was initiated as p lanned for residual ob sessiv e-comp ulsiv e symp toms. Carlos's symp toms imp rov ed initially, b ut he drop p ed out of treatment b ecause he did not think the therap y would work. Twelv e months after Carlos was discharg ed from the inp atient unit, his outp atient p sychiatrist initiated a slow titration of lamotrig ine to 2 0 0 mg /day, b ased on data from a recent op en-lab el trial showing effi cacy of adjunctiv e lamotrig ine in p atients with schiz op hrenia and schiz oaffectiv e disorder with comorb id ob sessiv e-comp ulsiv e symp toms (2 ) . After 1 0 weeks of lamotrig ine aug mentation, Carlos's ob sessiv e-comp ulsiv e symp toms decreased b y ab out 4 0 % while his p sychotic symp toms remained in remission. Carlos returned to his job at the g rocery store. tamination, symmetry or exactness, forbidden thoughts (aggressive, sexual, religious, and somatic), and hoarding (17) . These obsessional themes are typically associated with corresponding compulsions: cleaning, ordering and arranging, checking, and hoarding. Data from the DSM-IV field trial of 431 adults with OCD showed that only 2.1% of patients reported obsessions without compulsions and only 1.7% reported compulsions without obsessions.
In contrast, the delusions seen in patients with schizophrenia include persecutory, referential, somatic, erotomanic, and grandiose themes (10) . This is true even of the overvalued ideas seen in patients who are in a putative prodromal stage (C. Corcoran, unpublished 2010 data). Psychotic beliefs are more often "bizarre" ("clearly implausible and not understandable and do not derive from ordinary experiences"); however, bizarreness can be difficult to judge, especially across cultures (10, p. 299). Although "somatic" themes overlap between the two disorders, somatic thoughts that are bizarre or represent loss of control over mind or body (e.g., "My saliva is corroding my intestines") are more common in schizophrenia than in OCD with poor insight (10) . Likewise, religious themes can occur in both, but in OCD, patients are overly concerned with sacrilege, blasphemy, or scrupulosity (i.e., excessive concern with right and wrong or with morality), whereas in schizophrenia, patients may more commonly have grandiose religious delusions (e.g., "I'm a divine messenger"). Furthermore, loss of control, or "agency" of thinking, more commonly occurs in schizophrenia. Patients with OCD often consider their obsessions as products of their own thinking, whereas patients with schizophrenia often believe that there is some external agency or cause to what they are experiencing and thinking (18) . This distinction, however, becomes blurred when considering individuals with attenuated psychotic symptoms in a putative prodromal stage of schizophrenia or in patients with schizophrenia whose psychotic symptoms are partially remitted or residual. Also, a sense of permeation of ego boundary is more typical of schizophrenia than of OCD, although most patients with schizophrenia also have an intact sense of ego boundary (18) ; this concept has been explored phenomenologically by many notable figures, including Matussek, Jaspers, and Stephens and Graham (19) (20) (21) . However, the problem with these distinctions is that they are less clear in prodromal or evolving stages of illness or with partial remission of symptoms during residual phases. For example, young people at heightened risk for schizophrenia have attenuated psychotic symptoms and can retain insight that their experiences are likely the product of their own imagination, although doubt may exist as to their source and nature (22) (23) (24) (25) .
Comp ulsions V ersus R ep etitiv e B ehav iors. In adults with OCD, compulsive behaviors are typically performed in response to an obsession and to reduce distress or prevent a dreaded event. In contrast, in schizophrenia, repetior her thoughts and the link between his or her thoughts and compulsions, it is clearly OCD. However, in the patient who does not have hallucinations or disorganized speech but has psychotic beliefs and repetitive behaviors, it can be a challenge to distinguish the delusion of schizophrenia from the obsession of OCD if the patient has poor or no insight. Kurt Schneider defined a delusion of schizophrenia as "a perception that has a unique and idiosyncratic meaning for a person, which leads to an immediate delusional interpretation" (11, p. 1434). However, this definition could equally apply to the obsession of a patient with OCD who lacks insight. From a developmental perspective, "overvalued ideas" (i.e., subthreshold delusions-compelling ideas that have not yet achieved a level of conviction consistent with delusions) in an adolescent or a young adult might reflect emerging obsessions, the forme fruste of the fixed false beliefs that are delusions, or both. Another challenge in some cases is to distinguish the repetitive behaviors of schizophrenia from the compulsions of OCD. Both challenges are not uncommon given that many patients with OCD have variable insight into the rationality of their beliefs (in the DSM-IV field trial of OCD, 4% of patients had no insight and 26% had very little insight into the senselessness of their symptoms [12] ) and up to 35.5% individuals with schizophrenia have been found to exhibit repetitive behaviors (e.g., grooming, pacing, and hoarding), as shown in a study of 400 inpatients who met DSM-III-R criteria for schizophrenia (13) . In the absence of biomarkers or behavioral tests that can distinguish these features, careful attention to four aspects of the clinical phenotype can help in evaluation, as described in the following section.
Ev aluation

Time of Onset of Symptoms
Age at onset is similar for both OCD and schizophrenia, with 50% of OCD cases starting by age 19 and 20%-40% of first psychotic symptoms in schizophrenia starting by age 20 (14, 15) . In both disorders, subsyndromal symptoms can start in adolescence. However, time of onset of symptoms in relationship to changes in medication can exclude diagnoses. For example, if the first evidence of obsessive-compulsive symptoms or an exacerbation of existing symptoms occurs after initiating antipsychotic treatment for psychosis, one should consider the possibility that the symptoms are medication induced (4) . Similarly, if psychotic symptoms worsen after initiating or titrating an SRI, one should consider the possibility of medicationinduced psychosis (4, 16) .
Nature of Symptoms
O b sessions V ersus D elusions. Obsessions and delusions are both thought distortions. However, the content and character of the distortions, as well as their relationship to repetitive behaviors, can differ. In OCD, several common obsessive themes have been described: con-phrenia is appropriate given the patient's functional decline for more than 6 months and the presentation of criterion A psychotic symptoms-hallucinations (the "lines") and persecutory delusions-in the absence of an affective episode, concurrent substance use, or a coexisting medical condition. The diagnosis of OCD is made because Carlos had thought distortions with the prototypical theme of symmetry or exactness, which were accompanied by the compulsions of ordering and arranging, done specifically to reduce the anxiety associated with the thoughts. Furthermore, when not thought disordered, Carlos had full insight that these thoughts were the product of his own imagination, and he found them unreasonable and excessive. These characteristics differentiate obsessions from delusions or overvalued ideas, as are found, respectively, in schizophrenia and its putative prodromal stage. His compulsions were clearly not the disorganized behavior or stereotypies seen in some cases of schizophrenia, as they were functionally linked to his obsessive thoughts (i.e., he felt driven to rearrange things in response to his obsessive fear that he would not do things "just right"). As is required for a diagnosis of OCD, these obsessions and compulsions were time consuming (taking up more than 1 hour a day) and interfered with his functioning (10) . Thus, Carlos met DSM-IV criteria for both disorders. Several groups propose that the diagnosis of comorbid OCD and schizophrenia, also known as "schizo-obsessive" or "schizo-OCD," be made only when DSM-IV criteria for both disorders are met and OCD severity is at least moderate (i.e., eligible for entry into most OCD research studies) (4, 41) . Carlos met all three conditions.
Treatment
Treatment for schizophrenia includes pharmacotherapy with antipsychotics and psychosocial treatments (15) . CBT is used to treat both positive and negative symptoms of schizophrenia (42) . It typically consists of developing a shared understanding of the illness between patient and therapist, identifying positive and negative symptoms and triggers, linking thoughts and feelings about current symptoms, and then rationally reevaluating these thoughts in relation to the symptoms (43) .
The treatment approach to OCD is different. The two first-line treatments are pharmacotherapy with SRIs and CBT using exposure and response prevention (44) . Because SRIs typically reduce symptom severity but do not eliminate all symptoms, augmentation is usually needed. There are two proven SRI augmentation strategies: exposure and response prevention and antipsychotics (44) . Antipsychotics as monotherapy are not considered to be effective in OCD (45) . Exposure and response prevention consists of patients voluntarily exposing themselves to feared stimuli (real or imagined) while refraining from performing their compulsions (46) . The theory is that as patients are exposed to their fearful stimuli, this response tive behaviors are often independent of thought content; as noted earlier, in one study more than one-third of 400 patients with schizophrenia had at least one severe repetitive behavior (13) . Eisen and colleagues (26) suggest that the presence of compulsions linked to obsessions may be a useful guide in diagnosing comorbid OCD in patients with schizophrenia.
Family History
Family history can help inform the differential diagnosis. Although both schizophrenia and OCD are heritable disorders, with higher concordance rates in monozygotic twins than in dizygotic twins (14, 15) , they do not appear to cosegregate. Families of patients with schizophrenia are more likely to have members with schizophrenia spectrum disorders, such as schizoaffective disorder and schizotypal personality disorder (27) . In contrast, families of patients with OCD are more likely to have what are called "OCD spectrum disorders" (including tic disorder, Tourette's syndrome, skin picking) and comorbid mood and anxiety disorders (28) .
Developmental Psychosocial Functioning
Both schizophrenia and OCD can lead to significant functional impairment in the work, family, and social domains (15, 29) . However, in contrast to OCD, social dysfunction is a core feature of schizophrenia (30) (31) (32) , and functional impairment is one of the DSM-IV criteria required for diagnosis. In schizophrenia, this social dysfunction is evident early (33) . It is first expressed subtly during the premorbid period in childhood as difficulty in establishing relationships (34) and social overreactivity (social anxiety, "acting out") in boys and underreactivity (withdrawal) in girls (35) . Likewise, adolescents at genetic risk for schizophrenia have poor peer engagement and unpopularity with peers (36, 37) . Active social withdrawal is a feature of the putative prodromal period in schizophrenia (22, 23, 38, 39) . Lack of interpersonal relatedness (i.e., diminished capacity for others to feel engaged and relate well to the individual) may also be characteristic of schizophrenia (40) . In addition to social dysfunction, negative symptoms (e.g., flat affect, avolition, and alogia) are a key clinical aspect of schizophrenia and can include social anhedonia. In contrast, lack of interpersonal relatedness and social anhedonia are not characteristic of OCD, and social dysfunction is not required for an OCD diagnosis. On the other hand, obsessive-compulsive symptoms can certainly lead to social dysfunction (29) .
Diagnosis and Rationale
Many clinicians would see Carlos's symptoms at the time of presentation to the inpatient unit as falling easily within the spectrum of schizophrenia given the patient's persecutory ideas and social decline. However, clinicians might differ in how they perceive Carlos's obsessive-compulsive symptoms. We believe that the diagnosis should include both schizophrenia and OCD. ramine (63) . Although no randomized clinical trials have yet been conducted to evaluate the efficacy of lamotrigine for patients with comorbid OCD and schizophrenia, these preliminary data suggest that glutamate modulators may be an area of interest for treatment-resistant patients with both psychotic and obsessive-compulsive symptoms.
As for psychological treatments, CBT using exposure and response prevention has clear efficacy for OCD, but its effectiveness for OCD comorbid with schizophrenia is unknown. For schizophrenia alone, one pilot study examined the effect of repeatedly and systematically exposing five patients with schizophrenia to their auditory hallucinations (64) . Neither the frequency nor the content of the hallucinations changed, but patients reported decreased anxiety and a greater sense of control over their hallucinations, suggesting that exposure techniques may help reduce anxiety due to hallucinations. These data raise the possibility of using exposure techniques for obsessivecompulsive symptoms in the context of schizophrenia. Unfortunately, Carlos was not able to complete a trial of exposure and response prevention because of his doubts about whether this treatment would work.
There are as yet no consensus guidelines for the treatment of the putative schizophrenia prodrome. Olanzapine has unclear efficacy and problematic side effects (65) , and one study reported efficacy with risperidone when administered in combination with CBT (66) . Similarly, although several studies have described comorbid diagnoses in putative schizophrenia prodrome (one case series of nine adolescent patients found that 44% met criteria for OCD), there are no consensus guidelines for treating comorbid diagnoses and putative prodromal schizophrenia (67) (68) (69) (70) . It remains unknown whether treating obsessive-compulsive symptoms in a putative schizophrenia prodrome has an effect on the natural course of either of these illnesses.
Conclusions
The case of Carlos highlights diagnostic and treatment issues when patients present with psychotic and obsessive-compulsive symptoms. In such cases, the differential diagnosis can include comorbid schizophrenia and obsessive-compulsive disorder, OCD with poor insight, and schizophrenia with antipsychotic-induced obsessivecompulsive symptoms. If the psychotic symptoms are subthreshold or attenuated in form, the patient may have OCD and putative prodromal schizophrenia. Four aspects of the clinical phenotype-time of onset of symptoms, nature of symptoms, family history, and developmental psychosocial functioning-can help differentiate between these diagnoses so that the clinical management can be optimized. In this case, the diagnoses arrived at were comorbid schizophrenia and OCD, and current treatment guidelines were followed: antipsychotic treatment was opwill habituate, their fears will be disconfirmed, and they will experience less anxiety over time.
A few studies have addressed how to treat patients with both schizophrenia and OCD (4, 44) . Based on these studies, OCD treatment guidelines (44) suggest that these patients should first be stabilized on a second-generation antipsychotic and the obsessive-compulsive symptoms subsequently treated by the addition of an SRI. Whether these patients require SRIs at the high doses needed in patients with OCD without a comorbid psychotic disorder is unclear: obsessive-compulsive symptoms in the context of psychotic disorder have been found to respond to lower doses of fluvoxamine (100-200 mg/day) than typically used in treatment of OCD (250-300 mg/day) (4). Poyurovsky and colleagues (4) proposed that those who do not respond to the steps above be switched to another SRI or clomipramine, to another second-generation antipsychotic, or to a first-generation antipsychotic with an SRI or clomipramine. If these strategies are ineffective, they propose clozapine at a low dosage (75-300 mg/day), SRI augmentation of clozapine, and finally ECT (4, 47) .
Combining antipsychotics and SRIs (e.g., fluvoxamine and clozapine; clomipramine and clozapine; paroxetine and risperidone or a phenothiazine) requires careful monitoring for drug-drug interactions and for possible exacerbation of obsessional or psychotic symptoms (4, 44) . In patients with co-occurring schizophrenia and OCD or obsessive-compulsive symptoms, if antipsychotic medication induces obsessive-compulsive symptoms, there are several options: waiting for spontaneous resolution (4-6 weeks), gradually reducing the dosage of antipsychotic, switching to another antipsychotic, adding an SRI to target the obsessive-compulsive symptoms (e.g., fluvoxamine, clomipramine, sertraline), or attempting a trial of exposure and response prevention (4, 44) . The evidence base for these approaches is limited.
Some patients with both schizophrenia and OCD, like Carlos, remain symptomatic despite the treatment recommendations listed above. It is interesting that Carlos's OCD symptoms seemed to improve after the initiation of lamotrigine at 200 mg/day. Recent data have implicated glutamatergic abnormalities in the pathophysiology of schizophrenia, OCD, and depression (48) (49) (50) (51) (52) (53) (54) (55) (56) (57) (58) . Lamotrigine is an anticonvulsant typically used for seizure disorders and maintenance treatment in bipolar disorder. In addition to its varied mechanisms of action, lamotrigine inhibits glutamate release. In schizophrenia, there is preliminary evidence that lamotrigine (at dosages of 200 mg/day and higher) might be effective for psychotic symptoms when added to clozapine (59-61) but not when added to antipsychotics other than clozapine (62) . In OCD, an open-label study found that one of eight patients responded to lamotrigine augmentation of an SSRI (although the lamotrigine dosage was only 100 mg/day), and there has been a case report of marked improvement with lamotrigine augmentation (150 mg/day) of clomip-timized and SRIs and exposure and response prevention were tried. However, although clozapine effectively treated the symptoms of schizophrenia, Carlos's OCD continued to cause impairment because the SRIs were ineffective and the patient was not able to continue exposure and response prevention. On the other hand, the augmentation of clozapine treatment with lamotrigine, a glutamate modulator, appeared to reduce his OCD symptoms.
This case highlights clinical questions that future research can address: Can glutamate modulators be effective in treatment-resistant patients who have both psychotic and obsessive-compulsive symptoms? Given the efficacy of exposure and response prevention for OCD, is it a safe and effective option for patients with comorbid schizophrenia and OCD who are stabilized on antipsychotics? Since obsessive-compulsive symptoms can be an early developmental manifestation of emerging schizophrenia with or without OCD, what is the impact of treating the obsessive-compulsive symptoms during a putative prodromal stage in reducing the risk of developing schizophrenia and/or OCD? To address these issues, we need longitudinal studies of young people at risk for psychosis or for OCD to inform our understanding of the phenomenology and pathophysiology of these disorders in a developmental context, specifically focusing on finding potential biomarkers that can inform preventive strategies. Dr. Rodriguez has received research support from NARSAD, the New York Office of M ental H ealth Policy Scholar Program, and NIM H . Dr. C orcoran has received research support from NARSAD, the Lieber C enter for Schizophrenia Research, the Sackler Foundation, the Irving C enter for Translational Research, and NIM H . Dr. Simpson has been a member of the scientific advisory board for Jazz Pharmaceuticals, has received donated medication from Janssen for an NIM Hfunded study, and received an unrestricted grant from Neuropharm to explore novel medications for obsessive-compulsive disorder. Dr. Simpson has received research support from NARSAD and NIM H .
